Why do healthy volunteers participate in clinical trials?

Documenti analoghi

• Letter to the Editor of the British Journal of Clinical Pharmacology Re: van Iersel et al. (2026)—Why do healthy volunteers participate in clinical trials? doi: https://doi.org/10.1002/bcp.70499
  di: Kasra Shakeri‐Nejad, et al.
  Pubblicazione: (2026)
• Epidural methadone and morphine pharmacokinetics and clinical effects in healthy volunteers: A randomized, crossover‐design trial
  di: Alexander Hincker, et al.
  Pubblicazione: (2024)
• Safety, tolerability and pharmacokinetics of DNDI‐6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants
  di: Jean‐Yves Gillon, et al.
  Pubblicazione: (2025)
• Repeated intradermal lipopolysaccharide challenge responses in healthy volunteers: Implications for clinical pharmacology studies
  di: Alexandra A. J. Sillé, et al.
  Pubblicazione: (2026)
• Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease
  di: Muhammad Waqas Sadiq, et al.
  Pubblicazione: (2024)